Tuesday, 02 January 2024 12:17 GMT

Share Buy-Back Program


(MENAFN- GlobeNewsWire - Nasdaq) COMPANY ANNOUNCEMENT NO 59/2025 - December 1, 2025

On August 26, 2025, Royal Unibrew initiated a share buy-back program, cf. company announcement no. 44/2025.

The program is carried out under Art. 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014, on market abuse, as amended (the Market Abuse Regulation - MAR) and the Commission Delegated Regulation (EU) No 2016/1052 of March 8, 2016.

The share buy-back program is expected to be realized in the period from August 27, 2025, to December 19, 2025. The total transaction value of the share buy-backs in the period will not exceed DKK 300m.
The following transactions on Nasdaq Copenhagen A/S have been made under the program:

Number of
Shares
Average purchase price DKK Transaction value, DKK
Accumulated, last announcement 491,000 490.36 240,765,105
November 24, 2025 3,000 547.50 1.642.500
November 25, 2025 3,000 552.55 1.657.650
November 26, 2025 4,000 554.05 2.216.200
November 27, 2025 4,000 559.32 2.237.280
November 28, 2025 4,000 559.26 2.237.040
Total accumulated under the program 509,000 492.64 250,755,775

With the transactions stated above Royal Unibrew owns a total of 1,112,042 shares, corresponding to 2.3% of the share capital. The total amount of shares in the company is 50,200,000, including treasury shares.

For further information please contact:
Flemming Ole Nielsen (Head of Investor Relations)
E-mail:...
Telephone: +45 25 41 68 04

Encl.

Attachments

  • Fond-RU-59-2025-uk-SBB
  • Royal Unibrew SBB AUG-DEC 2025_24NOV-28NOV

MENAFN01122025004107003653ID1110420126



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search